From 2016 to 2021, industry revenue for contract pharma research is projected to increase at an annualized rate of 7.0% to $13.3 billion according to IBISWorld. Pharma companies have intensified research & development endeavors as a number of major blockbuster drugs face patent expiration.  Evaluate Pharma forecasts $215 billion in drug sales will be at risk due to generic competition between 2015 and 2020.